海外の治験の状況「1」での検索結果
65件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Available
- A controlled clinical trial to look at the effects of treatment with rufinamide on the body, thought process development and its safety in children aged 1 to 4 years with poorly controlled Lennox Gastaut Syndrome.
- Lennox Gastaut Syndrome MedDRA version: 13.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- France, Greece, India, Italy, United States
- 2011-05-19
Not Available
- A study into a combination treatment for HIV-1 in which the safety, absorption and elimination of a combination pill is compared to that of the individual components.
- Healthy Volunteers; Human immunodeficiency virus type 1 (HIV-1) MedDRA version: 20.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Netherlands
- 2020-01-20
Not Available
- First-in-human study of AT132 in X-Linked Myotubular Myopathy (XLMTM) Patients
- X-linked Myotubular Myopathy (XLMTM);Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- France, Germany, United Kingdom, United States
- 2018-05-25
Not Available
- International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones
- Philadelphia chromosome-positive acute lymphoblastic leukemia MedDRA version: 20.0 Level: LLT Classification code 10000845 Term: Acute lymphoblastic leukemia System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- France
- 2018-04-17
Not Available
- HLH-2004. Hemophagocytic Lymphohistiocytosis Study Group. Treatment Protocol of the Second International HLH Study 2004. - HLH-2004
- Hemophagocytic Lymphohistiocytosis (HLH), a life-threatening disease usually occurring in early childhood. HLH-2004 is an international treatment protocol which will be compared with the previous HLH-94 protocol. In HLH-2004 the cyclosporine treatment will be introduced at the start of therapy instead of after 8 weeks. Intrathecal therapy will consist of methotrexate in combination with prednisolone instead of methotrexate alone. Only a minority of the patients will receive intrathecal therapy.
- Norway
- 2005-08-26
Not Available
- A PHASE II, SINGLE-CENTRE, INVESTIGATOR-BLIND, PARALLEL GROUP CLINICAL TRIAL TO INVESTIGATE THE EFFICACY AND SAFETY OF 1% CICLOPIROX OLAMINE (BATRAFEN® CREAM), COMPARED TO 1% HYDROCORTISONE ACETATE (HC45® CREAM), COMPARED TO A TOPICAL EMOLLIENT (E45® CREAM), IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE ATOPIC ECZEMA
- Mild to moderate atopic eczema MedDRA version: 8.0 Level: LLT Classification code 10003641
- United Kingdom
- 2005-07-01
Not Available
- A Randomized, Double-Blind, Phase II Study Comparing the Anti-Retroviral Safety and Efficacy of Dexelvucitabine (DFC) 200 mg Once Daily to Lamivudine (3TC) 300 mg Once Daily in Addition to Optimized Background Therapy in HIV-1 Infected Subjects Who Have Failed and/or Harbor HIV with Resistance Mutations to NRTIs, PIs, and NNRTIs - DECLARE 1
- HIV-1
- United Kingdom
- 2006-02-24
Not Available
- A prospective, multicentre trial on the value of 18F-FET PET in the post-therapeutic evaluation of childhood brain tumours
- Children and adolescents with a primary brain tumour after first line therapy;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Germany
- 2014-01-14
Not Available
- Phase II, multicenter, randomized, adaptive, double-blind, placebo controlled study to assess safety and efficacy of olesoxime (TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients.
- Spinal Muscular Atrophy (type 2 or type 3 non ambulant patients aged 3-25 years) MedDRA version: 12.1 Level: LLT Classification code 10041582 Term: Spinal muscular atrophy
- Belgium, France, Germany, Italy, Netherlands, United Kingdom
- 2010-06-01
Not Available
- A 5-month research project for children aged from 1 year to 17 years who have high blood pressure in the lung, to see how well bosentan decreases this high blood pressure and improves children's physical capabilities compared to an inactive compound
- Pulmonary arterial hypertension (PAH) in children MedDRA version: 14.1 Level: LLT Classification code 10064908 Term: Associated with (APAH) System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders MedDRA version: 14.1 Level: LLT Classification code 10064909 Term: Idiopathic (IPAH) System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders MedDRA version: 14.1 Level: LLT Classification code 10064910 Term: Familial (FPAH) System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Argentina, Bulgaria, Chile, China, Colombia, Croatia, France, Guatemala, India, Mexico, Netherlands, Peru, Philippines, Portugal, Russian Federation, Serbia, South Africa, Ukraine, United States, Vietnam
- 2012-02-10
